Aclarion, Inc. (ACON)

0.1835 -0.0065 (-3.42%) At close: 04:00PM EDT

Aclarion, Inc.

8181 Arista Place
Suite 100
Broomfield, CO 80021
United States
833 275 2266
https://www.aclarion.com

Sector(s): Healthcare
Industry: Health Information Services
Full Time Employees: 4

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Jeffrey John Thramann M.D.	Executive Chairman	300k	N/A	1965
Mr. Brent Ness	CEO, President & Director	300k	N/A	1967
Mr. John Lorbiecki	Chief Financial Officer	225k	N/A	1963
Mr. Ryan Bond	Chief Strategy Officer	200k	N/A	1972

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Corporate Governance

Aclarion, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.